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Background  and purpose:  The  detection  of  atherosclerotic  lesions  in the  aorta  by transesophageal  echocar-
diography  (TEE)  is a marker  of  diffuse  atherosclerotic  disease.  Hyperuricemia  is  a  well-recognized  risk
factor for cardiovascular  diseases.  However,  no  data  are  available  concerning  the relationship  between
serum  uric  acid  (UA)  and  subclinical  thoracic  aortic  atherosclerosis.  We  aimed  to  investigate  the  associ-
ation between  thoracic  aortic  atherosclerosis  and  serum  UA  level.
Methods:  We  studied  181  patients  (mean  age  46.3  ± 8 years)  who  underwent  TEE  for various  indications.
Four  different  grades  were  determined  according  to intima–media  thickness  (IMT)  of thoracic  aorta.  UA
and other  biochemical  markers  were  measured  with  an automated  chemistry  analyzer.
Results:  TEE  evaluation  characterized  thoracic  aortic  intimal  morphology  as  Grade  1  in 69  patients,  Grade
2 in  52  patients,  Grade  3  in  31  patients,  and  Grade  4 in  29  patients.  The  highest  UA level  was  observed
in  patients  with  Grade  4 IMT  when  compared  with  Grade  1  and  2 IMT  groups  (p <  0.001  and  p  = 0.014,
respectively).  UA  levels  in patients  with  Grade  3 and  Grade  2  IMT  were  also  higher  than  patients  with
Grade  1 IMT  group  (p <  0.001,  for all). In multiple  linear  regression  analysis,  IMT  was  independently  associ-
ated with  UA  level  (  ˇ = 0.350, p <  0.001),  age  (ˇ =  0.219,  p  = 0.001),  total  cholesterol  (ˇ = −0.212,  p =  0.031),
low-density  lipoprotein  cholesterol  (ˇ = 0.350,  p  =  0.001),  and  high  sensitivity  C-reactive  protein  (hsCRP)
levels  (ˇ  =  0.148,  p =  0.014).
Conclusion:  Uric  acid  and  hsCRP  levels  are  independently  and  positively  associated  with  subclinical  tho-
racic  atherosclerosis.
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Uric acid (UA) is the ﬁnal product of purine nucleotides
etabolism. UA is a major antioxidant in human plasma [1].  How-
ver, UA has a more complex relationship to oxidative stress,
ossessing both scavenging properties and oxidizing and radical-
orming properties [2,3]. Serum UA is an independent risk factor
or cardiovascular disease [4,5]. Ultrasonographically measured
arotid intima–media thickness (IMT) is a marker for atheroscle-
otic disease [6] and serum UA levels were reported to be positively
orrelated with subclinical carotid atherosclerosis (AS) [7,8].Aortic atherosclerotic lesions detected on transesophageal
chocardiography (TEE) are markers of diffuse atherosclerotic
isease [9,10] and thoracic aortic IMT  was reported as an earlier
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marker of preclinical AS than carotid IMT  [11]. We  hypothesized
that UA level may  be related to thoracic AS, but the association
between thoracic aortic AS and serum UA level remains to be inves-
tigated in humans. Therefore, in the present study, we aimed to
assess the relationship between thoracic aortic AS with serum UA
level and other biochemical markers such as low-density lipopro-
tein (LDL) and high sensitive C-reactive protein (hsCRP) in patients
undergoing TEE examination for various indications.
Methods
Subjects
Of the 549 TEE procedures performed between January 2011 and
May  2012 in our clinic, we  evaluated 181 patients who had non-
atherosclerotic heart disease who  underwent TEE examination for
various indications (86 male, 95 female; mean age 45.2 ± 8.4 years),
which included evaluation and management of atrial ﬁbrillation
(62 patients), valvular heart disease (30 patients for mitral valve
vier Ltd. All rights reserved.
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iig. 1. Flow diagram of the study. TEE, transesophageal echocardiography; AF, atrial
VR,  mitral valve replacement; AVR, aorta valve replacement; AS, aortic stenosis; A
iabetes  mellitus; MS,  mitral stenosis; MR,  mitral regurgitation; PFO, patent forame
isease, 19 patients for aortic valve disease), and suspected atrial
eptal defect (70 patients) (Fig. 1).
Patients with known coronary artery disease or clinical signs
f ischemic heart disease, heart failure, peripheral vascular dis-
ase, kidney and liver diseases, malignancy, hypertension, diabetes
ellitus, and patients with history of carotid artery surgery or
troke besides current smokers were excluded from the study. We
lso excluded patients with familial hypercholesterolemia, aortic
issection, or aortic aneurysm, as well as the patients with poor
ltrasonographic recording quality with no clear delineation of the
ntima–media complex. In addition, patients taking anti-oxidant
rugs, diuretics, vitamins, and alcohol were also excluded from the
tudy. Positive exercise treadmill test was also an exclusion cri-
erion in our study. Institutional ethics committee approved the
tudy and written informed consent for participation in the study
as obtained from all individuals.
Age and gender were recorded and body mass index (BMI) was
omputed as weight divided by height squared (kg/m2).
ransthoracic and transesophageal echocardiography
Transthoracic echocardiography and TEE were performed in all
tudy subjects by using a commercially available system (Vivid
®, GE Medical Systems, Horten, Norway). Left ventricular ejection
raction (EF) was determined by Teichholz method [12].
All patients underwent TEE by using a multiplane trans-
sophageal transducer after a 4-h fasting period prior to the
rocedure. Subjects were placed in left decubitus with the left
rm under the head, which was kept in a ﬂexed position after
ropharyngeal anesthesia with lidocaine spray. The transducer was
ntroduced for visualization of the cardiac and aortic structures intoation; MVD, mitral valve disease; ASD, atrial septal defect; IE, infective endocarditis;
tic regurgitation; CAD, coronary artery disease; PAD, peripheral artery disease; DM,
le.
the esophagus and gastric cavity through the mouth. An experi-
enced cardiologist blinded to other laboratory results performed
TEE. TEE was well tolerated by all patients, and there were no
complications. A well-standardized protocol, which has been previ-
ously described, was  applied to cardiac examinations in all patients
[9]. All studies were recorded on videotape recorder and were inter-
preted independently by an experienced observer.
IMT  of the thoracic aorta was graded using a previously
described classiﬁcation [9].  The thoracic aorta was  considered nor-
mal  (Grade 1) when the intimal surface was  smooth and continuous
without lumen irregularities or increased echo density, with an inti-
mal  thickness less than 1.0 mm.  Grade 2 was deﬁned as a simple
atherosclerotic plaque with increased echo density of the intima
extending <3.0 mm into the aortic lumen. Grade 3 was deﬁned as
an atherosclerotic plaque extending ≥3.0 mm and <5.0 mm into the
aortic lumen. In Grade 4, the atherosclerotic plaque was ≥5.0 mm
in thickness.
Blood sampling
Blood samples were obtained following an overnight fasting
state just before TEE examination. Blood samples were centrifuged
at 3000 rpm for 10 min. Plasma samples were stored at −70 ◦C until
analysis for UA, hsCRP, triglyceride, total cholesterol, LDL, high-
density lipoprotein (HDL), and fasting glucose.
Measurement of biochemical markersPlasma UA, triglyceride, total cholesterol, LDL, HDL concen-
trations, and fasting glucose were measured with an automated
chemistry analyzer (Aeroset, Abbott, Abbott Park, IL, USA) by using
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Table 1
Comparison of demographic, clinical, and laboratory characteristics in groups.
Variables Grade 1 Grade 2 Grade 3 Grade 4 p-Value
(n  = 69) (n = 52) (n = 31) (n = 29) (ANOVA)
Age (years) 42.3 ± 8.4a 44.7 ± 8.2aa 47.4 ± 7.0 50.6 ± 7.2 <0.001
Male  gender n (%) 24 (34.8) 27 (51.9) 18 (58.1) 17 (58.6) 0.05×
BMI  (kg/m2) 26.7 ± 2.9 26.9 ± 3.6 26.4 ± 5.0 27.1 ± 3.1 0.869
SBP  (mmHg) 117.5 ± 11.4 117.6 ± 12.7 119.5 ± 13.8 117.2 ± 12.3 0.887
DBP  (mmHg) 74.4 ± 6.7 73.7 ± 9.2 74.5 ± 9.9 75.2 ± 8.5 0.882
EF  (%) 65.8 ± 3.7 65.4 ± 3.7 65.7 ± 4.3 66.3 ± 3.7 0.681
Glucose (mg/dl) 86.5 ± 8.5 85.2 ± 10.0 87.4 ± 9.9 87.1 ± 6.8 0.697
TC  (mg/dl) 187.7 ± 34.7b 206.3 ± 31.5 211.0 ± 30.3 210.2 ± 32.2 <0.001
LDL  (mg/dl) 114.3 ± 30.0c 132.9 ± 30.1cc 144.2 ± 27.0 146.025.8 <0.001
TG  (mg/dl) 143.7 ± 64.1 158.9 ± 73.2 149.8 ± 64.6 132.1 ± 53.4 0.331
HDL  (mg/dl) 44.7 ± 9.9d 41.6 ± 8.9dd 36.8 ± 7.7 37.8 ± 6.5 <0.001
Creatinine (mg/dl) 0.74 ± 0.16e 0.83 ± 0.18 0.80 ± 0.19 0.83 ± 0.16 0.011
Urea  (mg/dl) 30.8 ± 10.4 32.5 ± 9.8 29.8 ± 6.0 30.3 ± 7.2 0.546
hsCRP (mg/dl) 0.78 ± 0.64f 1.0 ± 0.77 1.19 ± 1.07 1.11 ± 0.99 0.082
Uric  acid (mg/dl) 3.91 ± 0.76b 4.74 ± 0.69g 4.91 ± 0.78 5.17 ± 0.74 <0.001
AF  n (%) 24 (29) 16 (30.8) 11 (35.5) 11 (37.9) 0.922×
VHD n (%) 15 (21.7) 20 (38.5) 6 (19.4) 8 (27.6) 0.148×
ASD suspicion n (%) 27 (39.1) 21 (40.4) 12 (38.7) 10 (34.5) 0.963×
BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; EF, ejection fraction; TC, total cholesterol; LDL, low-density lipoprotein; TG,  triglyceride;
HDL,  high-density lipoprotein; hsCRP, high sensitivity C-reactive protein; AF, atrial ﬁbrillation; VHD, valvular heart disease; ASD, atrial septal defect.
Signiﬁcance p values (p < 0.05) were indicated in boldface.
a p = 0.004 vs. Grade 3 group, p < 0.001 vs. Grade 4 group.
aa p = 0.002 vs. Grade 4 group.
b p < 0.001 vs. Grade 2, 3 and 4.
c p < 0.001 vs. Grade 3 and 4, p = 0.001 vs. Grade 2.
cc p = 0.05 vs. Grade 4.
d p < 0.001 vs. Grade 3 and 4.
dd p = 0.017 vs. Grade 3 group.
e p = 0.003 vs. Grade 2, p = 0.014 vs. Grade 4.
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pf p = 0.022 vs. Grade 3.
g p = 0.014 vs. Grade 4.
× Chi square test.
ommercial kits (Abbott). HsCRP was measured with an autoana-
yzer (Aeroset) by using a commercial spectrophotometric kit (Scil
iagnostics GmbH, Viernheim, Germany).
tatistical analysis
All analyses were conducted using SPSS 17.0 (SPSS for Win-
ows 17.0, Chicago, IL, USA). Continuous variables were expressed
s mean ± S.D. and categorical variables were expressed as per-
entages. Comparison of categorical variables between the groups
as performed using the Chi square (2) test. Analysis of normal-
ty was performed with the Kolmogorov–Smirnov test. Analysis
f variance (ANOVA) was used in the analysis of continuous vari-
bles. A stratiﬁed post hoc analysis of echocardiographic, clinical,
nd laboratory variables was performed according to the grade
f thoracic aortic IMT. Scheffe and Tamhane’s T2 tests were used
ccording to homogeneity test results. The correlation between
ortic IMT  and clinical and laboratory parameters was assessed
y the Pearson correlation test. Multiple linear regression analy-
is was performed to identify the independent predictors of aortic
MT  by including the parameters, which were correlated with aor-
ic IMT  in bivariate analysis. Standardized ˇ-regression coefﬁcients
nd their signiﬁcance from multiple linear regression analysis
ere reported. A two-tailed p < 0.05 was considered statistically
igniﬁcant.
esultsTEE evaluation characterized thoracic aortic intimal morphol-
gy as Grade 1 in 69 patients (38.1%), as Grade 2 in 52 patients
28.7%), as Grade 3 in 31 patients (17.1%), and as Grade 4 in 29
atients (16%).Comparison of demographic, clinical and laboratory
characteristics in groups
Comparison of demographic, clinical and laboratory character-
istics in groups is shown in Table 1. Age and gender were different
among the groups (p < 0.001, p = 0.05, respectively). Total choles-
terol level in the Grade 1 group was  lower than in the Grade 2,
3, and 4 groups (p < 0.001, for all). LDL cholesterol level in Grade 1
group was  lower compared with Grade 2, 3, and 4 groups (p = 0.001,
p < 0.001, and p < 0.001, respectively). Also, LDL  cholesterol level in
Grade 2 group was  lower than in Grade 4 group (p = 0.05). HDL
cholesterol level in Grade 1 group was lower than Grade 3 and 4
groups (p < 0.001 for both). HDL cholesterol level in the Grade 2
group was lower than in the Grade 3 group (p = 0.017). Creatinine
level in the Grade 1 group was  lower than in the Grade 2 and Grade
4 groups (p = 0.003, p = 0.014, respectively).
The highest UA level was observed in patients with Grade 4
IMT  (p < 0.001 and p = 0.014, compared with Grade 1 and 2 groups,
respectively). UA level of patients with Grade 3 and Grade 2 IMT
were also higher than patients with Grade 1 IMT  (p < 0.001, for
all). HsCRP level of Grade 1 group was  lower than Grade 3 group
(p = 0.022). HsCRP level in the Grade 4 group was  higher than in the
Grade 1 group, but this was  not statistically signiﬁcant (p = 0.072).
Bivariate and multivariate relationships of thoracic aortic IMT
Bivariate and multivariate relationships of thoracic aortic IMT
are shown in Table 2. Thoracic aortic IMT  was  associated with age
(r = 0.356, p < 0.001), gender (r = 0.154, p = 0.039), total cholesterol
(r = 0.241, p < 0.001), LDL cholesterol (r = 390, p < 0.001), HDL choles-
terol (r = −0.331, p < 0.001), creatinine level (r = 0.155, p = 0.037),
hsCRP level (r = 0.183, p = 0.014), and UA level (r = 0.491, p < 0.001)
in bivariate analysis.
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Table  2
Bivariate and multivariate relationships of thoracic aortic intima–media thickness.
Pearson correlation coefﬁcient p-Value Standardized  ˇ regression coefﬁcientsa p-Value
Age 0.356 <0.001 0.219 0.001
Gender 0.154 0.039 0.042 0.507
TC 0.241  <0.001 −0.212 0.031
HDL  −0.331 <0.001 −0.115 0.081
LDL  0.390 <0.001 0.350 0.001
Creatinine 0.155 0.037 −0.027 0.674
hsCRP  0.183 0.014 0.148 0.014
Uric  acid 0.491 <0.001 0.350 <0.001
AF 0.023 0.754
VHD −0.026 0.729
ASD suspicion −0.028 0.710
TC, total cholesterol; HDL, high-density lipoprotein; LDL, low-density lipoprotein; hsCRP, high sensitivity C-reactive protein; AF, atrial ﬁbrillation; VHD, valvular heart disease;
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aSD,  atrial septal defect.
igniﬁcance p values (p < 0.05) were indicated in boldface.
a Multiple linear regression analysis.
In multiple linear regression analysis, IMT  was independently
orrelated with UA level (  ˇ = 0.350, p < 0.001), age (  ˇ = 0.219,
 = 0.001), total cholesterol (  ˇ = −0.212, p = 0.031), LDL cholesterol
 ˇ = 0.350, p = 0.001), and hsCRP levels (  ˇ = 0.148, p = 0.014). The
elationship between thoracic aorta IMT  and UA is shown in Fig. 2.
ivariate and multivariate relationships of uric acid
UA level was associated with age (r = 0.152, p = 0.041), gen-
er (r = 0.251, p = 0.001), total cholesterol (r = 0.298, p < 0.001), LDL
holesterol (r = 0.351, p < 0.001), HDL cholesterol level (r = −0.344,
 < 0.001), creatinine (r = 0.189, p = 0.011) levels, and IMT  of thoracic
orta (r = 0.491, p < 0.001).
In multiple linear regression analysis, UA level was indepen-
ently correlated with gender (ˇ = 0.149, p = 0.023), HDL cholesterol
evel (  ˇ = −0.196, p = 0.004), and thoracic aortic IMT  (  ˇ = 0.373,
 < 0.001).
ivariate and multivariate relationships of thoracic aortic IMT
ithin the normal LDL cholesterol range (127 patients)
After the high LDL cholesterol values were excluded
>155 mg/dl), LDL cholesterol levels did not differ among the
roups (p = 0.814). According to bivariate analysis, thoracic aortic
MT  was signiﬁcantly associated with age (r = 0.336, p < 0.001),
A (0.373, p < 0.001), and hsCRP (r = 0.247, p = 0.005). Multivariate
egression analysis showed that the IMT  was independently
ig. 2. The relationship between thoracic aorta intima–media thickness and uric
cid.related to age (  ˇ = 0.274, p = 0.001), UA (  ˇ = 0.340, p < 0.001), and
hsCRP levels (  ˇ = 0.226, p = 0.004).
Discussion
The present study is the ﬁrst in the literature, which evalu-
ated the relationship between UA level and thoracic aorta IMT  in
patients without clinical manifestation of atherosclerotic cardio-
vascular disease whom were referred for evaluation by TEE. The
main ﬁnding of this study is that UA and hsCRP levels are indepen-
dently associated with thoracic aorta IMT  and these relationships
persisted even after taking into account traditional cardiovascular
risk factors.
The detection of atherosclerotic lesions on TEE in the aorta is a
marker of diffuse atherosclerosis [9,10].  Takasu et al. showed that
thoracic aortic calciﬁcation was associated with increasing severity
of carotid atherosclerotic burden as measured by carotid IMT  [13].
Recently, it was reported that aortic IMT  was an earlier marker
than carotid IMT  of preclinical AS [11]. In recent years, with the
development of preventive medicine, several studies on predictors
or risk factors of AS were conducted and plenty of factors in this
regard have been considered.
In this cross-sectional study, we demonstrated that thoracic
aorta IMT  is increased in the subjects with higher serum UA con-
centrations. This ﬁnding is important as it may  imply a tendency
to enhanced atherosclerosis in subjects with higher serum UA con-
centrations in early stages of life. Previous epidemiological studies
have demonstrated an inverse association between levels of UA
and atherosclerosis in humans [4,7,8].  In the study of Tavil et al.,
there were signiﬁcant correlations between carotid IMT measure-
ment, serum UA level, and other major atherosclerotic risk factors
[7]. In that study, the authors reported that higher serum UA
levels were associated with atherogenesis independent of hyper-
tension. In another study, Erdogan et al. reported that increased
serum UA concentration, even in physiological range, is a risk fac-
tor for increased carotid IMT, reduced ﬂow-mediated dilation, and
increased aortic stiffness independent of other cardiovascular risk
factors, and of factors related to the metabolic syndrome in healthy
subjects [8]. An independent relationship between thoracic aorta
IMT  and serum UA level in the present study supports ﬁndings of
previous studies reporting UA as a risk factor for initial AS [7,8].
Endothelial dysfunction plays a crucial role in the pathogenesis
of vascular diseases [14] as development of endothelial dysfunction
is regarded as a pioneer of atherosclerosis. Endothelial dysfunc-
tion might be enhanced by an imbalance characterized by reduced
nitric oxide production and/or increased reactive oxygen species
production [14,15]. In vivo studies have demonstrated that UA
can induce endothelial dysfunction by exerting anti-proliferative
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ffects on the endothelium and by impairing nitric oxide produc-
ion [2,16,17]. By the way of these mechanisms UA behaves as a
ro-oxidant in vascular cells, increasing lipid oxidization, impair-
ng endothelium-dependent vasodilation, and thereby potentially
iving rise to cardiovascular disease risk [2,3,18]. Conversely,
ncreased UA concentrations may  be a compensatory mechanism
rying to counteract oxidative stress [19,20]. In previous studies,
ith increased thoracic aortic IMT, oxidative stress is increased
21,22]. Therefore, highest UA level in Grade 4 IMT  may  be asso-
iated with increased oxidative stress. However, oxidative stress
arkers were not investigated in the present study.
The role of chronic inﬂammatory process in the development of
therosclerosis has been demonstrated in laboratory and experi-
ental investigations [23] and hsCRP, the most widely used marker
f inﬂammation, has been reported to be independently associ-
ted with cardiovascular diseases in a variety of clinical settings,
ncluding healthy subjects [24,25]. An independent association of
sCRP levels with thoracic aorta IMT  in the present study supports
revious studies revealing the role of chronic inﬂammatory pro-
ess, evidenced by increased hsCRP levels, in the development of
therosclerosis [23,24].
Coronary artery disease risk factors such as age, male gender,
ypertension, hyperlipidemia, and smoking have been associated
ith aortic AS [26,27]. In the present study, coronary risk factors
uch as serum lipid levels and age were independently associated
ith thoracic IMT. However, the impact of diabetes and hyperten-
ion on thoracic AS could not be concluded in our study as patients
ith hypertension and diabetes were excluded from the study.
ata revealing an association of grade of thoracic aorta AS and
erum lipid levels, in the present study, support Matsuzaki et al.
ho concluded that hypertension and hypercholesterolemia might
e important risk factors for the development of atherosclerotic
esions in the thoracic aorta in relatively younger patients [26] and
ishino et al. who identiﬁed hypercholesterolemia as a predictor
f thoracic aortic plaques [28].
In our study, UA level was associated with HDL cholesterol level
nd gender besides aortic IMT  in multiple linear regression analy-
is and these ﬁndings were consistent with literature revealing an
nverse relationship between UA and HDL levels [7,29].
tudy limitation
In our study, the patient population was enrolled from a diverse
opulation with several disease states, however thoracic aorta IMT
as not related to diagnosis of these patients. Additionally, coro-
ary angiography was not performed in our patients although the
iagnosis of coronary artery disease has been excluded according
o clinical characteristics and patient history, electrocardiography,
nd treadmill exercise test. Endothelial dysfunction was not inves-
igated in our study, although such an analysis would add to the
alue of the present study.
In conclusion, UA and hs-CRP are independently associated with
ubclinical thoracic atherosclerosis. Increases in both UA and hsCRP
ay  be crucial biochemical markers for initial AS.
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